Replies to post #133087 on Biotech Values

[mcbio]

BACE inhibitor in the clinic - AstraZeneca/AZD3839 from Astex (astx.com/pipeline/products/preclinical/), in phase I

clinicaltrials.gov/ct2/show/NCT01348737

ASTX's pipeline identifies the BACE inhibitor partnered with AZN as AZD3293 (http://astx.com/pipeline/products/preclinical#azdxxxx ) and it appears to be pre-clinical. Was AZD3839 shelved, re-named, or what?